Skip to main content

Table 3 Echocardiographic parameters

From: Coronary microvascular dysfunction is associated with degree of anaemia in end‐stage renal disease

  CFVR < 2 (n = 7) CFVR ≥ 2 (n = 15) p value
IVSD (mm) 12 ± 1 11 ± 2 0.610
LVIDD (mm) 46 ± 9 47 ± 6 0.679
PWD (mm) 10 ± 2 11 ± 2 0.789
LVIDS (mm) 31 (29–36) 30 (28–35) 0.535
FS (%) 33 ± 9 35 ± 5 0.639
LVEDVi (ml/m2) 55 (49–69) 44 (39–51) 0.115
LVESVi (ml/m2) 21 (18–28) 18 (16–21) 0.275
EF (%) 59 ± 7 59 ± 4 0.923
Stroke volume (ml) 87 ± 25 72 ± 20 0.182
Cardiac output (L/min) 6.1 ± 0.8 4.7 ± 1.4 0.02
GLS (%) -16 ± 3 -19 ± 2 0.107
TAPSE (mm) 21 ± 4 21 ± 5 0.875
LV mass index (g/m2) 99 ± 31 98 ± 28 0.936
LV geometry n (%)—normal geometry
Concentric remodelling
Eccentric hypertrophy
Concentric hypertrophy
2 (29)
3 (43)
1 (14)
1 (14)
4 (27)
1 (7)
3 (20)
7 (46)
0.237
LA volume index (ml/m2) 31.3 (26-44.1) 28.8 (20-38.3) 0.630
E/A ratio 1.1 (0.9–1.2) 0.8 (0.7–1.1) 0.340
E/e′ 9 (8–11) 8 (7–10) 0.123
  1. Data are presented as mean ± SD or median (IQR) .Variables highlighted in bold demonstrated a significant difference between the groups
  2. CFVR, coronary flow velocity reserve; IVSD, interventricular septal diameter; LVIDD, left ventricular internal diameter diastole; PWD, posterior wall diameter; LVIDS, left ventricular internal diameter systole; LVEDVi, indexed left ventricular end diastolic volume; LVESVi, indexed left ventricular end systolic volume; EF, ejection fraction; GLS, global longitudinal strain; TAPSE, tricuspid annular plane systolic excursion; LV, left ventricular.